{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:59:34Z","timestamp":1790096374791,"version":"4.0.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>Venous thromboembolism can be precipitated by both genetic and acquired factors, but the role of testosterone therapy is less clear. Here, we present a 17-year-old transgender adolescent, transitioning from female to male, receiving both estrogen and testosterone therapy, who developed a pulmonary embolism without an underlying genetic thrombophilic condition. As transgender medical care evolves, the use of testosterone as cross-sex hormone therapy in adolescents is likely to increase. Our review suggests that care must be taken when initiating treatment with testosterone, and modification of other thrombophilic risks should be explored before starting therapy in this population.<\/jats:p>","DOI":"10.1097\/mph.0000000000000984","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T21:48:40Z","timestamp":1506116920000},"page":"e38-e40","source":"Crossref","is-referenced-by-count":14,"title":["Hormone Therapy and Venous Thromboembolism in a Transgender Adolescent"],"prefix":"10.1097","volume":"40","author":[{"given":"Kaitlin","family":"Stanley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240202","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1538-7836.2005.01415.x","article-title":"Venous thromboembolism: disease burden, outcomes and risk factors","volume":"3","author":"Heit","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R2-20240202","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bmj.292.6519.526","article-title":"Oral contraceptives and venous thromboembolism: findings in a large prospective study","volume":"292","author":"Vessey","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R3-20240202","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.1963.03060020091034","article-title":"Oral contraception and venous thrombosis","volume":"185","author":"Tyler","year":"1963","journal-title":"JAMA"},{"key":"R4-20240202","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.2.5703.203","article-title":"Thrombotic disease and the steroidal content of oral contraceptives: a report to the committee on safety of drugs","volume":"2","author":"Inman","year":"1970","journal-title":"Br Med J"},{"key":"R5-20240202","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2002-021967","article-title":"Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects","volume":"88","author":"Moore","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20240202","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1507\/endocrj.EJ12-0319","article-title":"Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder","volume":"60","author":"Nakamura","year":"2013","journal-title":"Endocr J"},{"key":"R7-20240202","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"R8-20240202","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/EJE-09-0412","article-title":"Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals","volume":"161","author":"Jacobeit","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R9-20240202","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1743-6109.2007.00646.x","article-title":"Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females","volume":"5","author":"Gooren","year":"2008","journal-title":"J Sex Med"},{"key":"R10-20240202","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jth.12484","article-title":"Endogenous sex hormones and risk of venous thromboembolism in women and men","volume":"12","author":"Holmegard","year":"2014","journal-title":"J Thromb Haemost"},{"key":"R11-20240202","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1542\/peds.2014-0772","article-title":"Psychological and medical care of gender nonconforming youth","volume":"134","author":"Vance","year":"2014","journal-title":"Pediatrics"},{"key":"R12-20240202","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20240202","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/j.1743-6109.2008.00909.x","article-title":"Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals","volume":"5","author":"Meriggiola","year":"2008","journal-title":"J Sex Med"},{"key":"R14-20240202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/jc.2007-1809","article-title":"Long term treatment of transsexuals with cross-sex hormones: extensive personal experience","volume":"93","author":"Gooren","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20240202","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.trsl.2011.06.003","article-title":"Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia","volume":"158","author":"Glueck","year":"2011","journal-title":"Transl Res"},{"key":"R16-20240202","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1076029613485154","article-title":"Testosterone, thrombophilia and thrombosis","volume":"20","author":"Glueck","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"R17-20240202","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/MBC.0000000000000126","article-title":"Testosterone, thrombophilia, thrombosis","volume":"25","author":"Glueck","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R18-20240202","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/1076029608324930","article-title":"Pulmonary embolism associated with protein C deficiency and abuse of anabolic-androgen steroids","volume":"16","author":"Alhadad","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"R19-20240202","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejim.2007.03.016","article-title":"Pulmonary embolism associated with the use of anabolic steroids","volume":"19","author":"Liljeqvist","year":"2008","journal-title":"Eur J Intern Med"},{"key":"R20-20240202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1160\/TH15-01-0045","article-title":"Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILI Genetic Risk Monitoring (PILGRIM) Study","volume":"115","author":"Suchon","year":"2016","journal-title":"Thromb Haemost"},{"key":"R21-20240202","first-page":"66","article-title":"Contraception-related venous thromboembolism in adolescents","volume":"40","author":"O\u2019Brien","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"R22-20240202","first-page":"358","article-title":"Screening for a prothrombotic diasthesis in patients attending family planning clinic","volume":"112","author":"Kalev","year":"1999","journal-title":"N Z Med J"},{"key":"R23-20240202","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/AOG.0b013e3182699a2b","article-title":"Screening women for oral contraception: can family history identify inherited thrombophilias?","volume":"120","author":"Grimes","year":"2012","journal-title":"Obstet Gynecol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201801000-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T16:05:36Z","timestamp":1706889936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201801000-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000984","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}